Skip to main content

Table 3 Summary of reduction in mobile outreach visits if an administration of risperidone long-acting injection was not required (over a two-week period)

From: The cost associated with administering risperidone long-acting injections in the Australian community

Average Resource use ASGC region: Major Cities ASGC region: Inner Regional ASGC region: Outer Regional ASGC region: Remote & Very Remote
Mobile Outreach Visits by CMHC staff 1 Staff Visits ≥ 2 Staff Visits 1 Staff Visits ≥ 2 Staff Visits 1 Staff Visits ≥ 2 Staff Visits 1 Staff Visits ≥ 2 Staff Visits
Mobile outreach visits (no.) 9.3 4.6 6.6 2.7 3.2 1.2 4.0 2.14
Mobile outreach visits still required if a risperidone LAI administration was not required (no.) 7.6 3.7 5.2 2.1 1.9 0.7 3.1 1.86
Reduction in outreach visits (%) 18.0% 19.6% 21.2% 22.5% 41.7% 38.9% 21.4% 13.3%
National average reduction in mobile outreach visits if a risperidone LAI administration was not required      20%